slot game 49 jili

None

UCF and Tulsa will test their mettle against each other on Saturday afternoon in the Orange Bowl Basketball Classic in Sunrise, Fla. The Knights will make their first appearance in the event since recording a two-point loss to Missouri in 2022, while Tulsa's last trip to the Orange Bowl Classic was a loss to Florida State in 2012. UCF (7-2) may have something to prove being away from Addition Financial Arena. The Knights are 7-0 at home, whereas a November trip to the Greenbrier Tip-Off in West Virginia produced an 86-70 loss to Wisconsin and a triple-overtime setback against LSU. The Knights relied heavily on their defense in Sunday's 66-51 win over Tarleton State. After a sluggish start offensively, UCF found its rhythm during a 37-point second half. Jordan Ivy-Curry finished with a game-high 16 points and freshman center Moustapha Thiam collected 10 points, nine rebounds and six blocks. UCF's Big 12 opener draws closer (at Texas Tech, Dec. 31), but head coach Johnny Dawkins remains focused on daily improvement. "I feel a sense of urgency to get better, not with regards to Big 12 play to be quite frank, but every game," Dawkins said. "I don't look too far in the future. Pretty much I've always been in the moment as a player and as a person, and so for me it's about just getting better because it's our standards." Tulsa (4-6) looks to stop a three-game slide following a 70-66 home loss to Southern University last Saturday. Keaston Willis scored in double figures for the sixth time this season, netting a season-high 23 points off the bench. But Isaiah Barnes, one of three Golden Hurricane players to start all 10 games, was injured in the first half and played only eight minutes. To complicate matters, head coach Eric Konkol's team is 0-6 when trailing at halftime. "We got to get some guys healthy that can be healthy for next Saturday (against UCF)," Konkol said. "We got a couple other guys dealing with some different things, but then (also) having some planning to figure out what's the best way going forward for this group." --Field Level MediaSatellite Tech Could Help New Mexicans Get Good Internet

By Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.Thousands of Syrians celebrate in central Damascus during first Friday prayers since Assad's fall DAMASCUS (AP) — Thousands of Syrians celebrated in Umayyad Square, the largest in Damascus, after the first Muslim Friday prayers following the ouster of President Bashar Assad. The leader of the insurgency that toppled Assad, Ahmad al-Sharaa, appeared in a video message in which he congratulated “the great Syrian people for the victory of the blessed revolution.” Meanwhile, U.S. Secretary of State Antony Blinken said in the Turkish capital of Ankara that there was “broad agreement” between Turkey and the United States on what they would like to see in Syria. The U.S. diplomat also called for an “inclusive and non-sectarian" interim government. Nancy Pelosi hospitalized after she 'sustained an injury' from fall on official trip to Luxembourg WASHINGTON (AP) — Former House Speaker Nancy Pelosi has been hospitalized after she “sustained an injury” during an official engagement in Luxembourg, according to a spokesman. Pelosi is 84. She was in Europe to mark the 80th anniversary of the Battle of the Bulge in World War II. Her spokesman, Ian Krager, did not describe the nature of her injury or give any additional details, but a person familiar with the incident said that Pelosi tripped and fell while at an event with the other members of Congress. The person requested anonymity to discuss the fall because they were not authorized to speak about it publicly. Some in seafood industry see Trump as fishermen's friend, but tariffs could make for pricier fish PORTLAND, Maine (AP) — The incoming administration of President-elect Donald Trump is likely to bring big changes to seafood, one of the oldest sectors of the U.S. economy. Some in the industry believe the returning president will be more responsive to its needs. Economic analysts paint a more complicated picture, as they fear Trump’s pending trade hostilities with major trading partners Canada and China could make an already pricy kind of protein more expensive. Conservationists also fear Trump’s emphasis on deregulation could jeopardize fish stocks already in peril. But many in the commercial fishing and seafood processing industries said they expect Trump to allow fishing in protected areas and crack down on offshore wind expansion. Russia targets Ukrainian infrastructure with a massive attack by cruise missiles and drones KYIV, Ukraine (AP) — Russia has launched a massive aerial attack against Ukraine. Ukrainian President Volodymyr Zelenskyy says Russia fired 93 cruise and ballistic missiles and almost 200 drones in Friday's bombardments. He says it is one of the heaviest bombardments of the country’s energy sector since Russia’s full-scale invasion almost three years ago. He says Ukrainian defenses shot down 81 missiles, including 11 cruise missiles that were intercepted by F-16 warplanes provided by Western allies earlier this year. Zelenskyy renewed his plea for international unity against Russian President Vladimir Putin. But uncertainty surrounds how the war might unfold next year. President-elect Donald Trump has vowed to end the war and has thrown into doubt whether vital U.S. military support for Kyiv will continue. Veteran Daniel Penny, acquitted in NYC subway chokehold, will join Trump's suite at football game FORT LAUDERDALE, Fla. (AP) — A military veteran who choked an agitated New York subway rider and was acquitted of homicide this week has been invited by Vice President-elect JD Vance to join Donald Trump’s suite at the Army-Navy football game on Saturday. Daniel Penny was cleared of criminally negligent homicide in Jordan Neely’s 2023 death. A more serious manslaughter charge was dismissed last week. Vance served in the Marine Corps and had commented on the acquittal earlier this week. He said that “justice was done in this case” and Penny should never have been prosecuted. About 3 in 10 are highly confident in Trump on Cabinet, spending or military oversight: AP-NORC poll WASHINGTON (AP) — Americans may have elected Donald Trump to a second term in November, but that doesn’t mean they have high confidence in his ability to choose well-qualified people for his Cabinet or effectively manage government spending, the military and the White House. That's according to a new poll from the AP-NORC Center for Public Affairs Research. About half of U.S. adults are “not at all confident” in Trump’s ability to appoint well-qualified people for high-level government positions. Only about 3 in 10 are “extremely” or “very” confident that Trump will pick qualified people to serve in his administration. President Macron names centrist ally Bayrou as France's next prime minister PARIS (AP) — French President Emmanuel Macron has named centrist ally François Bayrou as prime minister, after a historic parliamentary vote ousted the previous government last week. The 73-year-old is a crucial partner in Macron’s centrist alliance and has been a well-known figure in French politics for decades. His political experience is seen as key in efforts to restore stability as no single party holds a majority in the National Assembly. Bayrou was recently cleared in a case relating to embezzlement of European Parliament funds. His predecessor resigned last week following a no-confidence vote prompted by budget disputes in the parliament, leaving France without a functioning government. Macron vowed last week to remain in office until his term ends in 2027. Rolling blackouts plague Iran and some suspect bitcoin mining may have a role in the outages TEHRAN, Iran (AP) — Iran’s capital and outlying provinces have faced rolling power blackouts for weeks in October and November, with electricity cuts disrupting people’s lives and businesses. And while there are likely several factors involved, some suspect that cryptocurrency mining has has a role in the outages. Iran's economy has been hobbled for years by international sanctions over its advancing nuclear program. The demand on the grid has not let up, however — even when Iranians stopped using air conditioners as the weather cooled in the fall and before winter months require people to fire up their gas heaters. Coincidence or not, bitcoin’s value is rocketing to all-time highs. McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales BOSTON (AP) — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia. McKinsey has also entered into a deferred prosecution agreement to resolve criminal charges, including that it conspired with Purdue Pharma to aid in the misbranding of prescription drugs. A former McKinsey senior partner has also agreed to plead guilty to obstruction of justice charges, according to the court papers. McKinsey said in a statement on Friday that it’s “deeply sorry” for its work for Purdue Pharma. Yankees to acquire closer Devin Williams from Brewers for Nestor Cortes, Chad Durbin, AP source says NEW YORK (AP) — A person familiar with the trade tells The Associated Press that the New York Yankees have agreed to acquire All-Star closer Devin Williams and cash from the Milwaukee Brewers for left-hander Nestor Cortes and infield prospect Caleb Durbin. A 30-year-old right-hander, Williams is eligible for free agency after the 2025 season. He was diagnosed during spring training with two stress fractures in his back and didn’t make his season debut until July 28.

Middle East latest: Israeli ministers approve a ceasefire deal with Hezbollah

Jordan Ivy-Curry, UCF aim to topple TulsaMiddle East latest: Israeli ministers approve a ceasefire deal with Hezbollah

Jordan Peterson says he’s left Canada and moved to the U.S.

Advisors Asset Management Inc. raised its stake in TD SYNNEX Co. ( NYSE:SNX – Free Report ) by 117.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,259 shares of the business services provider’s stock after acquiring an additional 679 shares during the quarter. Advisors Asset Management Inc.’s holdings in TD SYNNEX were worth $151,000 at the end of the most recent reporting period. Other institutional investors have also added to or reduced their stakes in the company. Hancock Whitney Corp grew its position in shares of TD SYNNEX by 57.9% during the 2nd quarter. Hancock Whitney Corp now owns 16,929 shares of the business services provider’s stock worth $1,954,000 after purchasing an additional 6,207 shares in the last quarter. Wedge Capital Management L L P NC grew its position in TD SYNNEX by 20.3% during the second quarter. Wedge Capital Management L L P NC now owns 31,146 shares of the business services provider’s stock worth $3,594,000 after buying an additional 5,252 shares in the last quarter. Friedenthal Financial bought a new position in TD SYNNEX during the 2nd quarter worth $967,000. ClariVest Asset Management LLC increased its stake in TD SYNNEX by 45,552.8% during the 2nd quarter. ClariVest Asset Management LLC now owns 16,435 shares of the business services provider’s stock worth $1,897,000 after acquiring an additional 16,399 shares during the period. Finally, Tidal Investments LLC raised its holdings in TD SYNNEX by 55.7% in the 1st quarter. Tidal Investments LLC now owns 17,508 shares of the business services provider’s stock valued at $1,980,000 after acquiring an additional 6,265 shares in the last quarter. 84.00% of the stock is currently owned by institutional investors. TD SYNNEX Stock Down 0.7 % NYSE:SNX opened at $118.99 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.25 and a quick ratio of 0.77. TD SYNNEX Co. has a one year low of $96.93 and a one year high of $133.85. The firm’s 50 day simple moving average is $119.22 and its 200 day simple moving average is $119.65. The company has a market cap of $10.12 billion, a PE ratio of 15.39, a P/E/G ratio of 1.21 and a beta of 1.48. TD SYNNEX Announces Dividend The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, October 11th were paid a $0.40 dividend. The ex-dividend date of this dividend was Friday, October 11th. This represents a $1.60 annualized dividend and a dividend yield of 1.34%. TD SYNNEX’s payout ratio is 20.70%. Analysts Set New Price Targets SNX has been the topic of a number of recent analyst reports. StockNews.com upgraded TD SYNNEX from a “hold” rating to a “buy” rating in a research report on Friday, August 16th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $140.00 price target on shares of TD SYNNEX in a report on Friday, September 27th. Barclays boosted their price objective on shares of TD SYNNEX from $131.00 to $132.00 and gave the company an “equal weight” rating in a research report on Friday, September 27th. Loop Capital reaffirmed a “buy” rating and issued a $150.00 target price on shares of TD SYNNEX in a report on Monday, October 7th. Finally, Barrington Research reissued an “outperform” rating and set a $138.00 price target on shares of TD SYNNEX in a report on Monday, September 23rd. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $134.75. View Our Latest Stock Analysis on TD SYNNEX Insider Transactions at TD SYNNEX In related news, insider Simon Leung sold 6,249 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $123.17, for a total transaction of $769,689.33. Following the completion of the sale, the insider now owns 23,339 shares of the company’s stock, valued at $2,874,664.63. This trade represents a 21.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website . Also, CFO Marshall Witt sold 5,653 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $121.15, for a total value of $684,860.95. Following the transaction, the chief financial officer now owns 38,279 shares in the company, valued at $4,637,500.85. The trade was a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold 69,645 shares of company stock worth $8,414,329 over the last ninety days. 1.90% of the stock is owned by insiders. TD SYNNEX Profile ( Free Report ) TD SYNNEX Corporation operates as a distributor and solutions aggregator for the information technology (IT) ecosystem. The company offers personal computing devices and peripherals, mobile phones and accessories, printers, supplies, and endpoint technology software; and data center technologies, such as hybrid cloud, security, storage, networking, servers, technology software, and converged and hyper-converged infrastructure, as well as computing components. See Also Five stocks we like better than TD SYNNEX Election Stocks: How Elections Affect the Stock Market The Latest 13F Filings Are In: See Where Big Money Is Flowing Ride Out The Recession With These Dividend Kings 3 Penny Stocks Ready to Break Out in 2025 Stock Analyst Ratings and Canadian Analyst Ratings FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for TD SYNNEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TD SYNNEX and related companies with MarketBeat.com's FREE daily email newsletter .A year of climate extremesYankees should avoid trading for White Sox star outfielder

J.K. Dobbins and Alohi Gilman are placed on injured reserve by Chargers